Cardiac-specific inducible overexpression of human plasma membrane Ca2+ ATPase 4b is cardioprotective and improves survival in mice following ischemic injury

Clinical Science
Al Muktafi SadiMansoor Husain

Abstract

Background: Heart failure (HF) is associated with reduced expression of plasma membrane Ca2+-ATPase 4 (PMCA4). Cardiac-specific overexpression of human PMCA4b in mice inhibited nNOS activity and reduced cardiac hypertrophy by inhibiting calcineurin. Here we examine temporally regulated cardiac-specific overexpression of hPMCA4b in mouse models of myocardial ischemia reperfusion injury (IRI) ex vivo, and HF following experimental myocardial infarction (MI) in vivoMethods and results: Doxycycline-regulated cardiomyocyte-specific overexpression and activity of hPMCA4b produced adaptive changes in expression levels of Ca2+-regulatory genes, and induced hypertrophy without significant differences in Ca2+ transients or diastolic Ca2+ concentrations. Total cardiac NOS and nNOS-specific activities were reduced in mice with cardiac overexpression of hPMCA4b while nNOS, eNOS and iNOS protein levels did not differ. hMPCA4b-overexpressing mice also exhibited elevated systolic blood pressure vs. controls, with increased contractility and lusitropy in vivo In isolated hearts undergoing IRI, hPMCA4b overexpression was cardioprotective. NO donor-treated hearts overexpressing hPMCA4b showed reduced LVDP and larger infarct size versus vehicle-tr...Continue Reading

References

Mar 27, 1995·Annals of the New York Academy of Sciences·G LemboK R Chien
Oct 1, 1996·Circulation Research·Z YuG I Fishman
Nov 29, 1996·The Journal of Biological Chemistry·A HammesL Neyses
Oct 20, 1999·Journal of Molecular and Cellular Cardiology·B L BiaK Clarke
Jan 12, 2001·Physiological Reviews·E E Strehler, D A Zacharias
Feb 22, 2001·Annual Review of Physiology·J D Molkentin, G W Dorn
Jan 24, 2002·Nature·Donald M Bers
Mar 14, 2002·The American Journal of Pathology·Michelle P BendeckStephanie M Farwell
May 15, 2003·Endocrinology·Robert GrosMansoor Husain
Aug 6, 2003·The Journal of Biological Chemistry·Kai SchuhLudwig Neyses
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jürgen Borlak, Thomas Thum
Apr 7, 2004·Circulation·Norbert FreyJoseph A Hill
Jan 16, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Susumu SakataRoger J Hajjar
Oct 13, 2009·American Journal of Physiology. Heart and Circulatory Physiology·Steffen BohlCraig A Lygate
Jan 19, 2010·Expert Opinion on Biological Therapy·Larissa LipskaiaRoger J Hajjar
Jul 26, 2011·Science China. Life Sciences·Elizabeth J CartwrightLudwig Neyses
Feb 19, 2013·The FEBS Journal·Marisa BriniErnesto Carafoli
Apr 18, 2013·Molecular Diagnosis & Therapy·Fabiana Filigheddu
Mar 29, 2014·Nature·Christine WahlquistMark Mercola
Mar 31, 2015·Journal of cardiology·Barry Greenberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

© 2022 Meta ULC. All rights reserved